Objective: To determine the levels of COVID-19-related fear and to investigate fear-associated factors among older people. Methods: This study was conducted with patients aged 65 years and older from the Family Medicine Clinic of Health Sciences University Şişli Hamidiye Etfal Hospital over a 1-month period. A telephone survey was administered to evaluate patients’ sociodemographic data and knowledge level on the COVID-19 pandemic and the degree of its impact. The fear levels of participants were determined using the fear of COVID-19 scale (FCV-19 S). Statistical analysis was performed using SPSS 15.0. A p value of < 0.05 was considered to be statistically significant. Results: The study included 315 participants: 178 were female and 137 were male. The mean age was 71.5 ± 5.6 (min: 65, max: 94) years, and 26 participants were living alone. Moreover, 47.6% participants considered they had sufficient information about the COVID-19 outbreak, and 61.6% received information about the pandemic from television and 22.2% from their inner circle. While 11.7% participants considered they would require psychological support after the COVID-19 pandemic, 30.8% had sleep disorders for the last month. The mean FCV-19 S score was 16.0 ± 6.4; the FCV-19 S scores were statistically higher in participants who were women, living alone, had partial information about the COVID-19 pandemic, had sleep disorders for the last month, and were in requirement of psychological support after the pandemic. Conclusion: It is necessary to screen the older people for the COVID-19-related fear and accompanying psychological disorders and to develop appropriate intervention programs for individuals at risk.
Background: YouTube has become a prominent source of health information, particularly during the COVID-19 pandemic. However, the quality and reliability of its content remain variable. This study aims to evaluate the impact of the pandemic on the quality, reliability, and informational structure of smoking cessation videos published on YouTube. Methods: This comparative descriptive content analysis included 600 YouTube videos collected across three periods: pre-COVID (November 2018–October 2019), mid-COVID (June 2020–May 2021), and post-COVID (June 2023–May 2024). For each period, the top 50 most-viewed and 50 randomly selected videos for the keywords “quit smoking” and “smoking cessation” were analyzed. After applying exclusion criteria, 271 videos were included. Video quality was assessed using the Journal of the American Medical Association (JAMA) Benchmark Criteria and Global Quality Score (GQS), while engagement metrics (view count, like ratio, watch time) were recorded. Results: Of the 271 videos, 66.8% were classified as useful, while 33.2% were misleading. A significant difference in content quality was observed across the three COVID-19 periods ( p = 0.017). Videos from the mid-COVID period were significantly more likely to be rated as useful and high-quality compared to the pre-COVID period ( p = 0.030), reflecting a temporary increase in content reliability during the pandemic peak. Educational content consistently showed the highest quality scores across all periods. In multivariable regression, GQS was the strongest predictor of perceived usefulness (OR for moderate vs. low = 38.9, p = 0.001). The logistic regression model demonstrated excellent discriminative performance, with an AUC of 0.912 (95% CI: 0.879–0.946; p < 0.001), effectively distinguishing useful from non-useful videos. Conclusion: The COVID-19 pandemic led to a transient improvement in the quality of smoking cessation content on YouTube, driven largely by contributions from healthcare professionals. However, the post-pandemic decline in content quality underscores the need for sustained digital health strategies and greater professional engagement to promote reliable online health information.
25 September 2021 in The Journal of Turkish Family Physician
Background: Smoking is one of the leading causes of preventable mortality worldwide. Smoking cessation treatments require personalized therapeutic approaches. Artificial intelligence (AI) is increasingly utilized in clinical decision support systems; however, its role in smoking cessation treatment remains underexplored. This study aims to evaluate the concordance between ChatGPT-4.0-generated treatment recommendations and physician decisions in smoking cessation therapy. Methods: This retrospective and descriptive study was conducted by reviewing the electronic records of patients who presented to a Smoking Cessation Clinic. The ChatGPT-4.0 model was used to compare AI-generated treatment recommendations with physician-prescribed therapies. Concordance rates and the quality of AI-generated information (inappropriate, useful, or perfect information) were assessed. Statistical analyses were performed using SPSS 25.0. Results: A total of 82 patient records were analyzed. The mean age was 40.71 ± 12.87 years (range: 19–69). The overall concordance rate between physicians and ChatGPT-4.0 was 67.1%. Regarding ChatGPT-4.0-generated information quality, 32.9% of cases received inappropriate recommendations, 36.6% received useful recommendations, and 30.5% received optimal recommendations. ChatGPT-4.0 provided inappropriate recommendations in 81.5% of cases involving chronic diseases and 77.8% of cases involving regular medication use (p = 0.021, p = 0.030, respectively). ChatGPT-4.0 achieved the highest rate of optimal recommendations (52.0%) for cytisine therapy. Conclusions: ChatGPT-4.0 can serve as a supportive tool in smoking cessation treatment. However, it remains insufficient in managing complex clinical cases, emphasizing the necessity of physician oversight in final decision-making. Enhancing AI models with larger and more diverse datasets may improve the accuracy of treatment recommendations.
30 September 2025 in Turkish Journal of Family Practice
Objective: This study aimed to compare the short-term (three-month) effectiveness of three smoking cessation therapies, bupropion, nicotine patch, and cytisine, and to retrospectively evaluate the impact of cytisine therapy on craving reduction and its side effect profile under routine clinical practice conditions. Methods: A total of 565 individuals who presented to the Smoking Cessation Outpatient Clinic between February 2024 and January 2025 and completed treatment with either cytisine, bupropion, or nicotine patch were included in the study. Demographic characteristics, chronic disease status, Fagerström Test for Nicotine Dependence (FTND) scores, and smoking cessation outcomes were assessed to compare treatment success across the three therapies. Among patients treated with cytisine, early craving reduction and reported side effects during the first week were recorded and analyzed in relation to cessation outcomes. Statistical significance was set at p
30 September 2024 in Clinical and Experimental Health Sciences
Objective: In this study, the aim is to evaluate the factors associated with nutrition, pressure ulcers, and fall risks in individuals receiving home health care. Methods: A retrospective study was designed by examining the files of the patients registered in the Home Health Care. Mini Nutritional Assessment Short Form, Modified Norton Scale and Itaki Fall Risk Scale scores were recorded. Results: The study included 334 patients. 197 (59%) of them were female and the mean age was 74.15±16.12 (min: 18, max: 101). The most common chronic diseases was hypertension (HT) (n=167, 50%), whereas the two most common comorbidities were DM and HT (n=77,23.1%). Patients receiving home health care were found to be at risk for malnutrition, pressure ulcers and falls. Being semi-bedridden and wheelchair bound were found to be predictors for the risk of developing pressure ulcers according to regression analysis results. Also it was identified that the age and dependency levels of the patients receiving home health care explained 12% of the falling behaviours of the older people. Conclusion: Necessary warnings should be given at every visit, so that receiving home health care should not be neglected in terms of risks and preventive measures should be taken for this patient group.